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Investigating the role of intensity in a comprehensive, aphasia therapy program: A non-
intensive trial of Aphasia LIFT. 
 
BACKGROUND 
Intensive, comprehensive aphasia programs (ICAPs) are an emerging service delivery 
in aphasia rehabilitation (Rose, Cherney, & Worrall, 2013). Positive therapeutic outcomes for 
the ICAP Aphasia LIFT (Language Impairment and Functioning Therapy) have been 
demonstrated across World Health Organisation International Classification of Functioning 
and Disability (ICF) domains (Rodriguez et al., 2013). Within aphasia rehabilitation, there is 
evidence favouring intensive treatment models (Cherney, Patterson, & Raymer, 2011; Robey, 
1998); however, the optimal treatment intensity for even one type of aphasia therapy is yet to 
be established (Cherney, 2012). Evidence from the neurosciences literature, based 
predominantly on animal studies of stroke rehabilitation, suggests that optimal learning 
outcomes are achieved when training is provided intensively (i.e., many hours per day) 
(Kleim & Jones, 2008). In contrast, studies of learning in healthy humans suggest that 
optimal long-term learning is achieved when training is distributed over time (Cepeda, 
Pashler, Vul, Wixted, & Rohrer, 2006).  This study evaluated the therapeutic effect of non-
intensive Aphasia LIFT (NiLIFT) on impairment and functional communication outcomes in 
adults with chronic aphasia.  
 
METHOD 
Study design 
A multiple baseline, pre/post-test design was utilised to evaluate the acquisition and 
maintenance of treatment gains. Three therapy trials were conducted (NiLIFT1, NiLIFT2, 
NiLIFT3). 
Participants 
Nine adults (1 F, 8 M) aged 47–76 years (mean = 60 years) with chronic aphasia 
following a left cerebral stroke were recruited to participate in the study (Table 1). All 
participants were >4 months post stroke at the commencement of the study (mean TPO = 
41.4 months, range 9–225 months) and spoke fluent English prior to their stroke.  Individuals 
with comorbid neurological impairments and/or severe apraxia of speech or dysarthria were 
not eligible to participate.  
Study Procedures 
Assessment. A comprehensive cognitive and communication assessment battery was 
conducted prior to therapy for all participants. Measures of participants’ language impairment 
and functional communication were collected immediately post-treatment and at 4 weeks 
follow-up.   
Goal Setting. A collaborative goal-setting session was conducted prior to 
commencing therapy in order to identify participants’ communication goals.  Individual 
language profiles were used to assist goal setting and to develop individualised treatment 
plans.  
Therapy. Individuals with aphasia and their significant communication partners 
(when available) participated in an 8 week trial of NiLIFT. A total of 51 hours of treatment 
was provided, which equated to approximately 7 hours of therapy per week (see Figure 1). 
Therapy tasks were individually tailored for participants and consisted of a combination of 
treatment approaches (i.e., impairment-based treatment, functional treatment, computer-based 
training and group sessions), as per previous Aphasia LIFT trials (Rodriguez et al., 2013).   
 
RESULTS 
Individual and group-level analyses were conducted using Wilcoxon signed ranks 
test. Effect sizes (ES) were calculated to determine the magnitude of treatment effects (See 
Table 2).  
Eight participants completed the NiLIFT therapy trial (6 participants completed 99-
100% therapy hours; 2 participants completed 94-96% therapy hours). One participant 
(N3P3) withdrew from the study in week two due to medical reasons.  A second participant 
(N1P2) was unavailable for follow-up testing.  
Language Impairment 
Analysis of group data revealed a significant increase in word retrieval for treatment 
items (z = 2.52, p = .012, ES = 2.67) and control items (z = 2.32, p = .021, ES = 1.17), 
immediately post-treatment (Table 3). These effects were maintained for treatment (z = 2.37, 
p = .018, ES = 1.75) and control items (z = 2.03, p = .043, ES = 0.90) at follow-up. Analysis 
of individual participant data revealed six participants made significant improvements in 
word retrieval for treated items immediately post-treatment and this was maintained for four 
participants at follow-up (Table 4, Figure 2). Two participants made significant 
improvements in naming accuracy for control items immediately post-treatment and these 
improvements were maintained at follow-up.  
 There was no significant increase in confrontation naming as measured by the Boston 
Naming Test (Kaplan, Goodglass, & Weintraub, 2001) immediately post-treatment, however, 
a small but significant treatment effect was found at follow-up (z = 2.207, p = .027, ES = 
0.17).  
Functional Communication 
An increase of 35.4% and 34.8% on the Communication Effectiveness Index (Lomas 
et al., 1989) indicate that NiLIFT had a positive therapeutic effect on participants’ functional 
communication immediately post-treatment (z = 2.21, p = .027, ES = 1.82) and at follow-up 
(z = 2.20, p = .028, ES = 1.73), respectively. 
An increase of 11.2% immediately post-treatment (z = 2.1, p = .036, ES = 0.74) and 
18.6% at follow-up (z = 2.20, p = .028, ES = 1.04) on the Communication Confidence Rating 
Scale for Aphasia (Babbitt & Cherney, 2010) indicate that NiLIFT had a positive therapeutic 
effect on individuals’ confidence participating in daily communication interactions.  
 
CONCLUSIONS 
 The results of this study provide support for a non-intensive model of Aphasia LIFT. 
Overall, NiLIFT was found to have a positive effect on participants’ language impairment 
and functional communication. At the individual level, all participants were found to improve 
on at least one communication measure across ICF domains. Furthermore, for many 
participants these treatment gains were enduring at follow-up. Further analysis of the data, 
with consideration of participants’ language and cognitive profiles, will contribute to our 
knowledge of the factors that influence therapy outcomes. Comparisons of this study with the 
high-intensity Aphasia LIFT study will help to establish our understanding of optimal 
treatment intensity for aphasia intervention.  
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Table 1 
 
Demographic Information  
 
Participant Gender         Age  MPO        Speech/Language Deficits                           
                                                                                      
N1P1 M  76  13  Severe anomia; severe 
comprehension deficits 
    
N1P2 M  47  9  Moderate anomia; moderate AOS 
 
N1P3 F  62  38  Severe anomia; severe 
comprehension deficits 
 
N2P1 M  71  17  Moderate-severe anomia; 
moderate comprehension deficits 
 
N2P2 M  64  225  Moderate anomia; mild-moderate 
AOS 
 
N2P3 M  55  23  Moderate anomia 
 
N3P1 M  58  16  Mild receptive deficits; moderate 
anomia; mild AOS  
 
N3P2 M  53  11  Mild anomia 
 
N3P3 M  54  21  Mild-moderate receptive deficits; 
mild anomia 
                       
N1= NiLIFT 1; N2= NiLIFT 2; N3= NiLIFT 3; MPO = Months post-onset; AOS= apraxia of 
speech 
Table 2 
 
Benchmarks for Effect sizes (ES). 
   
  Individual Data*   Group Data** 
   
Small  4.0     0.2 
    
Medium 7.0     0.5 
    
Large  10.1     0.8 
*Busk & Serlin d1 statistic (Beeson & Robey, 2006); ** Cohen’s d (Cohen, 1988) 
 
Table 3 
 
Group-level Data  
   
     Baseline  Post-Treatment Follow-Up 
30 Treatment Items 
     n=8   n=8   n=7 
Mean (SD)   9.0 (3.14)  23.75 (7.15)  20.43 
(9.01) 
 Range    5.0 – 15.0  12.0 – 30.0  7.0 - 29.0 
 
30 Control Items 
     n=8   n=8   n=7 
 Mean (SD)   8.83 (3.27)  16.13 (8.18)  14.43 
(8.44) 
 Range    5.3 – 16  3 – 27   3 - 29 
 
BNT 
     n=8   n=8   n=7 
Mean (SD)   27.88 (20.20)  30.50 (19.68)  31.43 
(21.66) 
 Range    2.0 – 59.0  2.0 – 58.0  3.0 – 60.0 
 
CETI 
     n=6   n=6   n=6 
Mean (SD)   55.7 (12.72)  75.43 (8.59)  75.08 (9.44) 
 Range    40.40- 70.0  65.0- 88.90  2.61- 8.19 
 
CCRSA 
     n=8   n=8   n=7 
Mean (SD)   68.4 (9.65)  76.0 (10.85)  79.2 (11.26) 
 Range    51.0 - 79.5  61.0 – 91.5  65.0 - 92.0 
       
BNT= Boston Naming Test; CETI= Communicative Effectiveness Index; CCRSA= Communication Confidence 
Rating Scale for Aphasia 
Table 4 
Individual effect sizes for naming accuracy of 30 treatment items and 30 control items. 
   
Participant Treatment Items    Control Items 
   
Post-Treatment Follow-Up  Post-Treatment Follow-Up 
N1P1 
   2.24   1.76   1.46   0.66 
N1P2 
   16.74**  na.   4.54   na. 
N1P3 
   5.77*   1.15   -1.75   -1.75 
N2P1 
   14.0**   10.0**   2.89   4.62 
N2P2  
   11.55**  9.81**   6.0   5.0 
N2P3  
   7.18**   6.80**   14.0**   9.0** 
N3P1 
   4.05**   3.66**   4.62**   2.31** 
N3P2 
   1.34   1.20   2.09   2.75 
Busk & Serlin d1 statistic: 4.0 = small, 7.0 = medium, 10.1 = large (Beeson & Robey, 2006);  
*p < .05; **p < .01; na. = not available 
  
  
Figure 1. Therapy schedule for an 8 week distributed trial of Aphasia LIFT.  
  
Figure 2. Individual naming performance on 30 treatment items at baseline (average), post-
therapy and follow-up assessments.  
 
